The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bipolar Disorders and Treatment Market Research Report 2025
Synopsis
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.
The global Bipolar Disorders and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorders and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorders and Treatment.
Report Scope
The Bipolar Disorders and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorders and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorders and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka Holdings
AstraZeneca
Segment by Type
Mood Stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety
Segment by Sale Channel
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bipolar Disorders and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.
The global Bipolar Disorders and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorders and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorders and Treatment.
Report Scope
The Bipolar Disorders and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorders and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorders and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka Holdings
AstraZeneca
Segment by Type
Mood Stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety
Segment by Sale Channel
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bipolar Disorders and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorders and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mood Stabilizer
1.2.3 Anticonvulsant
1.2.4 Antipsychotic
1.2.5 Antidepressant
1.2.6 Antianxiety
1.3 Market by Sale Channel
1.3.1 Global Bipolar Disorders and Treatment Market Growth by Sale Channel: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorders and Treatment Market Perspective (2019-2030)
2.2 Bipolar Disorders and Treatment Growth Trends by Region
2.2.1 Global Bipolar Disorders and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bipolar Disorders and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Bipolar Disorders and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Bipolar Disorders and Treatment Market Dynamics
2.3.1 Bipolar Disorders and Treatment Industry Trends
2.3.2 Bipolar Disorders and Treatment Market Drivers
2.3.3 Bipolar Disorders and Treatment Market Challenges
2.3.4 Bipolar Disorders and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorders and Treatment Players by Revenue
3.1.1 Global Top Bipolar Disorders and Treatment Players by Revenue (2019-2024)
3.1.2 Global Bipolar Disorders and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Bipolar Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorders and Treatment Revenue
3.4 Global Bipolar Disorders and Treatment Market Concentration Ratio
3.4.1 Global Bipolar Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorders and Treatment Revenue in 2023
3.5 Bipolar Disorders and Treatment Key Players Head office and Area Served
3.6 Key Players Bipolar Disorders and Treatment Product Solution and Service
3.7 Date of Enter into Bipolar Disorders and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorders and Treatment Breakdown Data by Type
4.1 Global Bipolar Disorders and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Type (2025-2030)
5 Bipolar Disorders and Treatment Breakdown Data by Sale Channel
5.1 Global Bipolar Disorders and Treatment Historic Market Size by Sale Channel (2019-2024)
5.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Sale Channel (2025-2030)
6 North America
6.1 North America Bipolar Disorders and Treatment Market Size (2019-2030)
6.2 North America Bipolar Disorders and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bipolar Disorders and Treatment Market Size by Country (2019-2024)
6.4 North America Bipolar Disorders and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bipolar Disorders and Treatment Market Size (2019-2030)
7.2 Europe Bipolar Disorders and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bipolar Disorders and Treatment Market Size by Country (2019-2024)
7.4 Europe Bipolar Disorders and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorders and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Bipolar Disorders and Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bipolar Disorders and Treatment Market Size (2019-2030)
9.2 Latin America Bipolar Disorders and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bipolar Disorders and Treatment Market Size by Country (2019-2024)
9.4 Latin America Bipolar Disorders and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorders and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Bipolar Disorders and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bipolar Disorders and Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bipolar Disorders and Treatment Introduction
11.2.4 Pfizer Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorders and Treatment Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Bipolar Disorders and Treatment Introduction
11.5.4 Allergan Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.5.5 Allergan Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Bipolar Disorders and Treatment Introduction
11.6.4 Novartis Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Bipolar Disorders and Treatment Introduction
11.7.4 AbbVie Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Otsuka Holdings
11.8.1 Otsuka Holdings Company Detail
11.8.2 Otsuka Holdings Business Overview
11.8.3 Otsuka Holdings Bipolar Disorders and Treatment Introduction
11.8.4 Otsuka Holdings Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.8.5 Otsuka Holdings Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorders and Treatment Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorders and Treatment Business (2019-2024)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
